Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia · Delayed Price · Currency is MYR 1.100
-0.020 (-1.79%)
At close: Sep 21, 2026
Pharmaniaga Berhad Balance Sheet
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 34.84 | 54.3 | 68.68 | 114.74 | 52.85 | 47.11 |
Short-Term Investments | 117.47 | 223.27 | 67.36 | 2.87 | 4.11 | 10.25 |
Cash & Short-Term Investments | 152.31 | 277.57 | 136.04 | 117.61 | 56.96 | 57.36 |
Cash Growth | 2.28% | 104.04% | 15.67% | 106.48% | -0.70% | 40.85% |
Accounts Receivable | 733.92 | 324.55 | 337.63 | 285.22 | 261.75 | 227.85 |
Other Receivables | 7.52 | 97.52 | 86.98 | 84.4 | 76.77 | 44.1 |
Receivables | 741.44 | 422.06 | 424.6 | 369.62 | 338.52 | 271.95 |
Inventory | 757.9 | 729.82 | 612.79 | 580.64 | 767.26 | 1,264 |
Prepaid Expenses | - | 16.49 | 11.06 | 26.9 | 32.06 | 27.52 |
Restricted Cash | - | 18.3 | 19.8 | 12.7 | - | - |
Total Current Assets | 1,652 | 1,464 | 1,204 | 1,107 | 1,195 | 1,621 |
Property, Plant & Equipment | 622.99 | 602.78 | 609.36 | 605.75 | 443.03 | 395.59 |
Goodwill | 76.9 | 77.03 | 77.31 | 77.47 | 77.34 | 129.48 |
Other Intangible Assets | 12.47 | 22.65 | 28.25 | 23.8 | 72.39 | 75.31 |
Long-Term Deferred Tax Assets | 51.45 | 28.15 | 27.34 | 52.08 | 48.89 | 33.07 |
Long-Term Deferred Charges | 71.66 | 51.97 | 45.76 | 48.3 | 10.83 | 3.23 |
Total Assets | 2,487 | 2,247 | 1,992 | 1,915 | 1,847 | 2,258 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,100 | 776.48 | 650.1 | 627.78 | 648.02 | 677.63 |
Accrued Expenses | 0.35 | 40.47 | 96.19 | 91.6 | 46.78 | 31.53 |
Short-Term Debt | 463.37 | 527.49 | 771.26 | 711.18 | 681.3 | 543.98 |
Current Portion of Long-Term Debt | 17.23 | 162.55 | 283.41 | 335.87 | 384.45 | 25.7 |
Current Portion of Leases | 1.54 | 3.99 | 4.48 | 4.62 | 5.67 | 1.57 |
Current Income Taxes Payable | 12.02 | 6.97 | 10.46 | 9.8 | 4.27 | 14.44 |
Current Unearned Revenue | 25.13 | 11.69 | 29.76 | 9.16 | 31.28 | 22.46 |
Other Current Liabilities | 16.39 | 81.45 | 107.43 | 212.44 | 265.93 | 150.46 |
Total Current Liabilities | 1,636 | 1,611 | 1,953 | 2,002 | 2,068 | 1,468 |
Long-Term Debt | 298.65 | 125.4 | 129.57 | 138.62 | 91.67 | 284.99 |
Long-Term Leases | 0.12 | 0.37 | 3.18 | 1.09 | 5 | 0.62 |
Long-Term Unearned Revenue | 19.53 | 15.22 | 14.51 | 3.1 | 3.36 | 3.62 |
Pension & Post-Retirement Benefits | 10 | 10.56 | 10.79 | 10.84 | 9.05 | 9.08 |
Long-Term Deferred Tax Liabilities | 25.74 | 25.05 | 27.13 | 32.85 | 18.82 | 21.35 |
Other Long-Term Liabilities | 14.5 | - | - | - | - | - |
Total Liabilities | 2,004 | 1,788 | 2,138 | 2,189 | 2,196 | 1,787 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 243.43 | 243.43 | 200.05 | 200.05 | 154.19 | 154.05 |
Retained Earnings | 128.26 | 97.06 | -471.41 | -603.42 | -525.23 | 293.73 |
Comprehensive Income & Other | 86.87 | 93.98 | 100.09 | 104.31 | 1.34 | 2.69 |
Total Common Equity | 458.56 | 434.47 | -171.28 | -299.07 | -369.69 | 450.46 |
Minority Interest | 24.34 | 24.69 | 25.33 | 24.98 | 21.39 | 19.98 |
Shareholders' Equity | 482.89 | 459.16 | -145.94 | -274.09 | -348.31 | 470.44 |
Total Liabilities & Equity | 2,487 | 2,247 | 1,992 | 1,915 | 1,847 | 2,258 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 780.91 | 819.79 | 1,192 | 1,191 | 1,168 | 856.86 |
Net Cash (Debt) | -628.6 | -542.22 | -1,056 | -1,074 | -1,111 | -799.5 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.51 | -0.75 | -3.66 | -3.93 | -4.24 | -3.05 |
Filing Date Shares Outstanding | 1,311 | 1,311 | 288.25 | 288.25 | 262.04 | 261.99 |
Total Common Shares Outstanding | 1,311 | 1,311 | 288.25 | 288.25 | 262.04 | 261.99 |
Working Capital | 15.98 | -146.85 | -748.78 | -894.98 | -872.9 | 153.43 |
Book Value Per Share | 0.35 | 0.33 | -0.59 | -1.04 | -1.41 | 1.72 |
Tangible Book Value | 369.19 | 334.79 | -276.83 | -400.33 | -519.43 | 245.68 |
Tangible Book Value Per Share | 0.28 | 0.26 | -0.96 | -1.39 | -1.98 | 0.94 |
Land | - | 394.94 | 393.11 | 394.01 | 25.66 | 25.55 |
Buildings | - | - | - | - | 254.02 | 255.22 |
Machinery | - | 503.78 | 503.2 | 497.02 | 444.29 | 430.76 |
Construction In Progress | - | 142.41 | 125.81 | 109.28 | 75.42 | 30.17 |